These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1716 related articles for article (PubMed ID: 24252804)

  • 1. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.
    Mukherjee UA; Ong SB; Ong SG; Hausenloy DJ
    Pharmacol Ther; 2015 Dec; 156():34-43. PubMed ID: 26481155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium signaling in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Cell Tissue Res; 2014 Aug; 357(2):439-54. PubMed ID: 24781149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
    Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury.
    Shahaduzzaman M; Acosta S; Bickford PC; Borlongan CV
    Med Hypotheses; 2013 Oct; 81(4):675-80. PubMed ID: 23920272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease model organism for Parkinson disease: Drosophila melanogaster.
    Aryal B; Lee Y
    BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
    Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
    Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO and Parkinson's disease.
    Eckermann K
    Neuromolecular Med; 2013 Dec; 15(4):737-59. PubMed ID: 23979994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.